SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

Share Price is delayed by 15 minutes
Get Live Data
4,490.00    -50.00 (-1.11%)
Bid:
4,400.00
Ask:
4,580.00
Spread: 180.00 (4.091%)
Market Cap: £296.40m
JDG Live PriceLast checked at - London Stock Exchange

Intraday Judges Scientific Share Chart

Trading Update

18 Nov 2024 07:00

RNS Number : 5845M
Judges Scientific PLC
18 November 2024
 

Press Release

18 November 2024

 

Judges Scientific plc

 

("Judges Scientific" or the "Company")

 

Trading Update

 

Judges Scientific, the group focused on acquiring and developing companies in the scientific instrument sector, today provides an update on trading.

 

As announced at the time of the Group's Interim Results in September, several of our Group businesses had experienced a challenging first half, driven by difficult market conditions and the deferral of some projects into H2 or 2025. We expected the second half to show significant improvement, with a number of agreements signed too late to impact the first half but contributing to the second, in addition to the signature of a 2025 coring contract.

 

As anticipated, H2 will show progress compared to H1. However, achievement of the expectations for the full year, which were revised downwards in July, was reliant upon the crystallisation and delivery of certain orders. We now believe these will not all occur in time to deliver against the expectations before the end of the year.

 

Organic order intake YTD to the end of October has progressed 4.2% vs 2023 including a coring contract by Geotek. Order intake would be 1.6% down if we excluded this contract, indicating that the general level of orders across the Group has not yet recovered to the growth path traditional for our Group.

 

As a result, the Board now expects Adjusted basic earnings per share for the year to 31 December 2024 to be between 270p and 300p.

 

In spite of the disappointing trading performance, the Board is confident that the long-term growth drivers of our business remain solid.

 

 

For further information please contact: 

 

Judges Scientific plc

David Cicurel, CEO

Brad Ormsby, CFO

Tel: +44 (0) 20 3829 6970

 

 

Shore Capital (Nominated Adviser & Joint Broker)

Stephane Auton

Harry Davies-Ball

Tel: +44 (0) 20 7408 4090

 

Panmure Liberum (Joint Broker)

Edward Mansfield

Nikhil Varghese

Tel : +44 (0) 20 3100 2222

 

 

Investec Bank plc (Joint Broker)

Virginia Bull

Carlton Nelson

Tel: +44 (0) 20 7597 4000

Alma (Financial Public Relations)

Sam Modlin

Joe Pederzolli

Rebecca Sanders-Hewett

Sarah Peters

Tel: +44 (0) 20 3405 0205

judges@almastrategic.com

 

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector. The Group consists of 25 businesses acquired since 2005.

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, scientific research facilities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group has received five Queen's Awards for innovation and export.

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the reduction of debt, organic growth and dividends.

For further information, please visit www.judges.uk.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFFIILRLDLIS
Date   Source Headline
19th Sep 20177:00 amRNSInterim Results for the 6M ended 30 June 2017
6th Sep 201711:10 amRNSDirector/PDMR Shareholding
6th Sep 201711:10 amRNSDirector/PDMR Shareholding
6th Sep 201711:08 amRNSDirector/PDMR Shareholding
8th Aug 20175:12 pmRNSDirector/PDMR Shareholding
8th Aug 20175:12 pmRNSDirector/PDMR Shareholding
8th Aug 20175:11 pmRNSDirector/PDMR Shareholding
1st Aug 20177:00 amRNSTotal Voting Rights
27th Jul 20177:00 amRNSNotice of Results
21st Jul 20179:51 amRNSDirector/PDMR Shareholding
21st Jul 20179:20 amRNSHolding(s) in Company
20th Jul 20171:57 pmRNSDirector/PDMR Shareholding
20th Jul 20177:00 amRNSTrading Update and Notice of Interim Results
18th Jul 20177:00 amRNSAcquisition
6th Jul 20174:15 pmRNSDirector/PDMR Shareholding
6th Jul 20174:12 pmRNSDirector/PDMR Shareholding
6th Jul 20174:11 pmRNSDirector/PDMR Shareholding
7th Jun 20172:49 pmRNSDirector/PDMR Shareholding
7th Jun 20172:48 pmRNSDirector/PDMR Shareholding
7th Jun 20172:46 pmRNSDirector/PDMR Shareholding
5th Jun 201711:31 amRNSHolding(s) in Company
24th May 201712:52 pmRNSResult of Annual General Meeting
15th May 20177:00 amRNSBlocklisting Return
10th May 20173:39 pmRNSDirector/PDMR Shareholding
10th May 20173:38 pmRNSDirector/PDMR Shareholding
10th May 20173:36 pmRNSDirector/PDMR Shareholding
10th May 20173:35 pmRNSDirector/PDMR Shareholding
2nd May 20177:00 amRNSTotal Voting Rights
28th Apr 20175:10 pmRNSDirector/PDMR Shareholding
7th Apr 20178:57 amRNSDirector/PDMR Shareholding
7th Apr 20178:55 amRNSDirector/PDMR Shareholding
7th Apr 20178:54 amRNSDirector/PDMR Shareholding
3rd Apr 20177:00 amRNSTotal Voting Rights
21st Mar 20177:00 amRNSFinal Results
8th Mar 20172:41 pmRNSDirector/PDMR Shareholding
8th Mar 20172:40 pmRNSDirector/PDMR Shareholding
8th Mar 20172:39 pmRNSDirector/PDMR Shareholding
1st Mar 20177:00 amRNSTotal Voting Rights
8th Feb 20173:50 pmRNSDirector/PDMR Shareholding
8th Feb 20173:45 pmRNSDirector/PDMR Shareholding
8th Feb 20173:40 pmRNSDirector/PDMR Shareholding
1st Feb 20177:00 amRNSTotal Voting Rights
23rd Jan 20177:00 amRNSTrading statement and Notice of Final Results
10th Jan 201712:10 pmRNSDirector/PDMR Shareholding
10th Jan 201712:05 pmRNSDirector/PDMR Shareholding
10th Jan 201712:00 pmRNSDirector/PDMR Shareholding
3rd Jan 20177:00 amRNSTotal Voting Rights
15th Dec 201611:52 amRNSDirector/PDMR Shareholding
13th Dec 20164:15 pmRNSDirector/PDMR Shareholding
13th Dec 20164:13 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.